| Literature DB >> 12039799 |
Spencer W Galt1, Stephan Lindemann, Loren Allen, Donald J Medd, Jeanne M Falk, Thomas M McIntyre, Stephen M Prescott, Larry W Kraiss, Guy A Zimmerman, Andrew S Weyrich.
Abstract
Matrix metalloproteinases (MMPs) are proteolytic enzymes that degrade extracellular matrix proteins. These enzymes are implicated in a variety of physiological and pathological events characterized by extracellular matrix remodeling. Recent studies suggest that MMPs may have a signaling capacity, but direct evidence supporting this concept is lacking. In the present study, we demonstrate that outside-in signals delivered by exogenous MMP-1 (interstitial collagenase) markedly increase the number of tyrosine-phosphorylated proteins in platelets. Active MMP-1 also targets beta(3) integrins to areas of cell contact and primes platelets for aggregation. Examination of the endogenous enzyme demonstrated that activated platelets process latent MMP-1 into its active form. Neutralization of MMP-1 activity with MMP inhibitors or specific blocking antibodies markedly attenuates agonist-induced phosphorylation of intracellular proteins, movement of beta(3) integrins to cell contact points, and intercellular aggregation. The finding that MMP-1 is rapidly activated in platelets and controls functional responses identifies a new role for this metalloproteinase as a signaling molecule that regulates thrombotic events.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12039799 DOI: 10.1161/01.res.0000019241.12929.eb
Source DB: PubMed Journal: Circ Res ISSN: 0009-7330 Impact factor: 17.367